Biotech Working On COVID-19 Therapies Raises $105M
Canadian biotechnology company AbCellera said Wednesday it raised $105 million from investors to help fund its technology for antibody drug discovery, which it's currently deploying to help develop therapies to prevent...To view the full article, register now.
Already a subscriber? Click here to view full article